
Fourteen compounding pharmacies have already applied for DQSA registration with FDA
Companies are positioning themselves as approved high-volume compounders
At a January 9
A Reuters
When—and if—the outsourcing facility status becomes entrenched in US drug distribution, there might be also an expansion of the friction between manufacturers (who choose certain formulations for their branded products—and not others) and these facilities, such as what has been occurring when Roche’s Genentech unit
Related to this article








